Belgium· BE-AMP-SAM330416-00
Vinblastine Teva 1 mg/ml
A vinblastine product containing vinblastine sulfate, registered in Belgium by Teva. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vinblastine is registered in 14 of 19 countries.
Countries holding a registration under ATC L01CA01 (vinblastine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Vinblastine · ATC L01CA01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vinblastine costs, country by country.
Normalised to the WHO defined daily dose (11.61 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vinblastine · price per daily dose (11.61 mg)
USD · FX 28 Sept 2026
- CH Switzerland$56.28
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Vinblastine Sulfate
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- L01CA01
- ATC class
- Vinblastine
- Defined daily dose
- 11.61 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2647808
- be_apb0793927
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
416 interactions on record for vinblastine.
Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vinblastine · interactions on record
416 records
- 61 severe
- 303 moderate
- 24 minor
- 28 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vinblastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVINBLASTIN TEVATeva Pharmaceuticals CR, s.r.o., Praha
- United KingdomVelbe 10mg powder for solution for injection vialsEli Lilly and Company Ltd
- GermanyVinblastin StadaStadapharm Gmbh
- FinlandVelbeSTADA Nordic ApS
- NorwayVelbeSTADA Nordic Aps
- CanadaVINBLASTINE SULFATE INJECTIONPFIZER CANADA ULC
- IrelandVinblastine Sulfate 1mg/ml Solution for Injection or InfusionPfizer Healthcare Ireland Unlimited Company
- NetherlandsVinblastinesulfaat 1 mg/ml PCH, oplossing voor injectiePharmachemie B.V.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Velbe
- Czechia · Vinblastin Teva
- Germany · Vinblastin Stada, Vinblastinsulfat Teva
- Denmark · Velbe
- Estonia · Vinblastine Teva
- Spain · Vinblastina Stada
- Finland · Velbe
- France · Velbe
- United Kingdom (Northern Ireland) · Vinblastine Sulfate Hospira Uk
- Ireland · Vinblastine Sulfate Pfizer Healthcare Ireland
- Italy · Velbe
- Lithuania · Vinblastine Teva
- Luxembourg · Vinblastine Teva
- Latvia · Vinblastine Teva
- Malta · Vinblastine Sulfate Pfizer Hellas
- Netherlands · Vinblastinesulfaat Pch
- Norway · Velbe
- Portugal · Solblastin
- Romania · Vinblastină Teva
- Sweden · Velbe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a080e18b-b213-48f3-b0c9-369865dd703b GET /v1/drugs/a080e18b-b213-48f3-b0c9-369865dd703b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Vinblastine Teva 1 mg/ml",
"name_fr": "Vinblastine Teva 1 mg/ml",
"name_nl": "Vinblastine Teva 1 mg/ml",
"amp_code": "SAM330416-00",
"strengths": [
"1.0000",
"1.0000",
"9.0000",
"9.0000"
],
"pack_count": 1,
"substances": [
"Vinblastine Sulfate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vinblastine",
"authorisation_numbers": [
"BE330416"
]
}See everything about vinblastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.